Journal article
Avoiding Mastectomy: Accelerated Partial Breast Irradiation for Breast Cancer Patients with Pacemakers or Defibrillators
Annals of surgical oncology, v 18(12), pp 3500-3505
01 Nov 2011
PMID: 21607774
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The objective of this study was to evaluate the safety, toxicity, and planning concerns involved in accelerated partial breast irradiation (APBI) for patients with breast cancer who have a pacemaker or an automatic implantable cardioverter-defibrillator (AICD) and who desire breast conservation.
We performed a review of prospectively obtained data for patients with early-stage breast cancer with a pacemaker or AICD treated between April 2007 and July 2010. Patients were treated with either 3D conformal external beam irradiation (3D-CRT) or high-dose rate balloon brachytherapy (HDRBB) as performed in the National Surgical Adjuvant Breast and Nowel Project (NSABP) B-39/Radiation Therapy Oncology Group (RTOG) 0413 protocol. Device interrogation was performed after the first and last radiation treatment, with comparative cardiac monitoring performed before and after the first three treatments.
Eight patients were treated and have a mean follow-up of 6 months. Three patients received HDRBB delivering 34 Gy in 10 fractions. Mean planning target volume for evaluation (PTV_EVAL) coverage was 93.6%. The maximum radiation dose delivered to any device was 1.03 Gy, with a mean pacemaker distance to lumpectomy cavity (DLC) of 9.1 cm. Five patients received 3D-CRT consisting of 38.5 Gy in 10 fractions. The mean 90% PTV_EVAL coverage was 97.3%. Maximum dose delivered to any device was 1.68 Gy at a DLC of 9 cm. Local toxicity did not exceed grade 1, and no adverse device events were noted.
APBI in patients with pacemakers or AICDs who desire breast preservation seems to be a technically safe and reasonable application of targeted radiation therapy.
Metrics
Details
- Title
- Avoiding Mastectomy: Accelerated Partial Breast Irradiation for Breast Cancer Patients with Pacemakers or Defibrillators
- Creators
- Randal Croshaw - Allegheny General HospitalYongbok Kim - Drexel UniversityErik Lappinen - Allegheny General HospitalThomas Julian - Allegheny General HospitalMark Trombetta - Allegheny General Hospital
- Publication Details
- Annals of surgical oncology, v 18(12), pp 3500-3505
- Publisher
- Springer Nature
- Number of pages
- 6
- Grant note
- Department of Health and Human Services U10-CA-37377; U10-CA-69974; U10-CA-12027; U10-CA-69651 / National Cancer Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Multidisciplinary Breast Fellowship Program U10CA069974 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine); Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000295844400038
- Scopus ID
- 2-s2.0-83055194725
- Other Identifier
- 991019167576704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Surgery